Other
Altitude
Altitude is an intervention with 4 clinical trials. Currently 2 active trials ongoing.
Total Trials
4
Max Phase
—
Type
OTHER
Molecule
—
Success Metrics
Active Trials
2(50%)
Phase Distribution
Ph not_applicable
3
75%
Ph phase_1
1
25%
Phase Distribution
1
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution4 total trials
Phase 1Safety & dosage
1(25.0%)
N/ANon-phased studies
3(75.0%)
Highest Phase Reached
Phase 1Trial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
2
trials recruiting
Total Trials
4
all time
Status Distribution
Active(2)
Other(2)
Detailed Status
Active, not recruiting2
Suspended1
unknown1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
2
Success Rate
N/A
Most Advanced
Phase 1
Trials by Phase
Phase 11 (25.0%)
N/A3 (75.0%)
Trials by Status
suspended125%
active_not_recruiting250%
unknown125%
Recent Activity
2 active trials
Showing 4 of 4
active_not_recruitingnot_applicable
Identifying Biological Markers for Altitude Exposure and Use of Recombinant Human Erythropoietin (rHuEPO)
NCT04227665
suspendedphase_1
NASA Prebreathe Study
NCT06740305
active_not_recruitingnot_applicable
Effect of Rehabilitation on the Respiratory Signal in Patients With COPD and Exercise-Induced Desaturation
NCT07107828
unknownnot_applicable
Human Adaptation to High Altitude
NCT01627652
Clinical Trials (4)
Showing 4 of 4 trials
NCT04227665Not Applicable
Identifying Biological Markers for Altitude Exposure and Use of Recombinant Human Erythropoietin (rHuEPO)
NCT06740305Phase 1
NASA Prebreathe Study
NCT07107828Not Applicable
Effect of Rehabilitation on the Respiratory Signal in Patients With COPD and Exercise-Induced Desaturation
NCT01627652Not Applicable
Human Adaptation to High Altitude
All 4 trials loaded
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 4